Ronald P. Hattis, MD, MPH President, Beyond AIDS December 2013 (based on a presentation at California State University, San Bernardino, 10/4/12)

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.
Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
Part A/Module A1/Session 4 Part A: Module A1 Session 4 Comprehensive Care for People Living with HIV/AIDS (PLHA)
HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.
HIV True or False Module HIV/AIDS Activity 2: HIV:True or False.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Chapter 8 Depression and Human Immunodeficiency Virus Francine Cournos, MD Karen McKinnon, MA Mark Bradley, MD Copyright © World Psychiatric Association.
Ronald P. Hattis, MD, MPH Associate Clinical Professor Department of Preventive Medicine Loma Linda University Presented August 30, 2013 Based on a residency.
HIV and AIDS: Protecting Yourself, Protecting Others David Lee, Mollie Williams, and Andrew Frankart.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Chapter 21 Preview Bellringer Key Ideas What Are HIV and AIDS?
EPIDEMIOLOGY Epidemiology of chronic kidney injury, including prevalence and prognosis in various community groups. Screening of populations for kidney.
Chapter 25 HIV/AIDS and STIs
Sexually Transmitted Infections & HIV/AIDS
4. HIV/AIDS in Africa Takashi Yamano Development Issues in Africa Spring 2007.
Kinds of STIs Chlamydia Gonorrhea Genital Warts Genital Herpes
LIMPOPO PROVINCIAL MEN’S SECTORS/BROTHERS FOR LIFE PRESENTED BY: RAPAKWANA JOHANNAH MANAGER:GAAP in HIV & AIDS & STIs Directorate DEPT OF HEALTH AND SOCIAL.
 Human Immunodeficiency Virus -  AIDS  There are some drugs that can keep it at HIV  Some people never get AIDS because of drugs nowadays  Disease.
SEXUALLY TRANSMITTED DISEASES
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
Health Disparities Affecting Minorities African Americans.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Resource Needs Model Rachel Sanders October 28 th, 2010.
HIV INFECTION D - preventive Medicine. HIV INFECTION LEARNING OBJECTIVES  Describe the pathophysiology of HIV infection.  Describe the principal mechanisms.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
AIDS. What is AIDS  Applies to the most advanced stages of HIV infection.  CDC defines AIDS as all HIV infected people who have fewer than 200 CD4 positive.
10 facts about AIDS Source: World Health Organization
HIV and AIDS. AIDS (Acquired immune deficiency syndrome)- a disease in which the immune system of the patient is weakened. HIV (Human immunodeficiency.
Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.
Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.
G ENERAL P RINCIPLES OF P REVENTION A ND C ONTROL OF C OMMUNICABLE D ISEASES.
From good epidemiological ideas to policy and legislation: The case of Beyond AIDS Ronald P. Hattis, MD, MPH President, Beyond AIDS Presented at California.
Session: 3 The four pronged approach to comprehensive prevention of HIV in infants and young children Dr.Pushpalatha, Assistant Professor, Dept of Pediatrics,
Pagare Maya & Yewale Sakhu. 1. We aimed at desiging on all purpose 9 th and 10 th std. students give the information of aids. Create the scientific attitude.
Application.  Classifying Diseases  Chronic/Acute  Communicable/Noncommunicable  Communicable Disease Model  Chain of Infection.
BY NICK BUTTS, JACK CARMUSIN, MARK BLAUER, CHARLES SPORN STD’s and avoiding Pregnancy.
New Prevention Technologies Workshop Module 2: NPTs in context
NUR 431.  A discipline that provides structure for systematically studying health, disease, and conditions related to health status ◦ Distribution of.
INTRODUCTION TO SYNDROMIC MANAGEMENT OF STIs
Pharmacy in Public Health: Levels of Disease Prevention Add course Date here.
Control & prevention OFS.T.I. ALI ASGHAR FARAZI MD. MPH.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
HIV and AIDS. HIV – human immunodeficiency virus attacks specific cells of the immune system disabling the body’s defenses against other pathogens. AIDS.
Lesson 1 & 3. Objectives  Identify high risk behaviors that put teens at a great risk for STD infection  Understand how HIV effects the body and its.
Important diseases and their global impact Objectives To be able to describe the causes and means of transmission of malaria, AIDS/HIV and T.B To be able.
كلية العلوم الصحية بالليث
The 5 Stages of Disease and Prevention: A New Classification System
Health Education Behaviour and Health
INTRODUCTION: CERVICAL CANCER SCREENING
WHO strategy on HIV/AIDS “Getting to Zero”
October 24, 2014 Learning Targets:
STRATEGIES FOR STI PREVENTION AND CONTROL
What’s Your Health IQ? True or False
101, Prevention, Stages, & Treatment
transmission, prognosis, and social issues
BELIEFS, VALUES, AND HEALTH
BELIEFS, VALUES, AND HEALTH
HIV and AIDS.
BELIEFS, VALUES, AND HEALTH
HIV and AIDS.
BELIEFS, VALUES, AND HEALTH
What is palliative care?
BELIEFS, VALUES, AND HEALTH
Medical-Surgical Nursing: Concepts & Practice
Management of HIV/AIDS
What do HIV and AIDS stand for?
Presentation transcript:

Ronald P. Hattis, MD, MPH President, Beyond AIDS December 2013 (based on a presentation at California State University, San Bernardino, 10/4/12)

The Stages of Prevention: A new paradigm (Hattis and Law, 2009) The development of diseases (esp. chronic) generally involves 5 stages, and each lends itself to preventive interventions: 1. Exposure to agents/causes/risk factors of disease 2. Acquisition of early disease due to exposure 3. Progression of acquired disease from early to advanced 4. Complications resulting from advanced disease 5. Death or Disability, generally from complications 2

The Stages of Prevention: A new paradigm, contd. Each stage of disease development has a corresponding stage of prevention Stage 1: Avoidance of exposure to agents of disease Sexual abstinence; anti-smoking efforts Stage 2: Reduction of acquisition of disease (as a result of exposure) Post-exposure prophylaxis; hepatitis B vaccine for drug users Stage 3: Interruption of the progression of a disease (that has been acquired) Screening tests (Pap, cholesterol, etc.) followed by treatment; INH for latent TB; some diseases can be cured or progression reversed Stage 4: Avoidance of complications (from progressed disease) Prophylactic antimicrobials for AIDS patients; anticoagulants Stage 5: Delay of mortality, rehabilitation of disability, or palliative care for terminal disease ICU care for stroke; physical therapy; hospice care 3

The Stages of Prevention applied to HIV/AIDS Stage 1: Avoiding exposure - abstinence; sex only with faithful partners with both seronegative; not sharing needles Stage 2: Mitigating exposure/harm reduction – condoms; needle exchange; post-exposure prophylaxis Stage 3: Interruption of transmission (and of secondary infection) – screening; early treatment Stage 4: Avoiding complications – antimicrobials, treating metabolic effects Stage 5: Keeping complications from getting worse – hospital care of infections; rehabilitation; palliative care 4

Applying Stages of Prevention model to individual counseling - Stage 1 prevention to avoid exposure to the disease (e.g., abstinence, not using drugs) - Stage 2 prevention to avoid infection despite exposure (e.g., condoms, needle exchange) - Stage 3 prevention to detect infection and treat it to avoid AIDS (e.g., get tested for HIV; take antiretroviral drugs if infected and CD4 count dropping, which also reduces exposure of partners) - Stage 4 prevention to prevent complications of AIDS (e.g., antimicrobial drugs added to antiretroviral drugs) - Stage 5 prevention after an episode of an opportunistic infection (e.g., treatment of the infection) 5

Applying Stages of Prevention model to public health planning Each consecutive stage is targeted at a smaller population (a potential cost saving), but may be more expensive or difficult to apply to each member of that population as become more ill Example: Hospitalization for advanced diseases/complications Examples of exceptions: - Changing behavior or an entire population to reduce risky sex or drug use (Stage 1) may be difficult and expensive per capita - Trimethoprim-sulfa to prevent complications of AIDS (Stage 4) is inexpensive for each person treated As each stage of prevention is applied, it can reduce the rate of its respective stage of disease development and of all subsequent stages, so early stage prevention pays off Example: If fewer acquire disease, fewer complications occur 6

Using the Stages of Prevention for calculations of rates Ultimately, the death rate in a defined population p per year or other time period t, due to complication- specific mortality, D/(p*t), is equal to the product of five factors: E/(p*t ), the exposures per defined population per year A/ E, the rate of disease acquisition per exposed persons P/ A, the progression rate of acquired disease per acquired cases C/ P, the rate of complications per cases of progressed disease D / C, the complication-specific death rate 7

Using the Stages of Prevention for calculations of rates, contd. The rate of an earlier stage will be the product of the rates of the stages up to that point; examples (note the algebraic cancellations): The incidence rate of the disease is A /(p*t) = E/(p*t) * A/E The rate of a specific complication within the defined population is C/(p*t) = E/(p*t) * A/E * P/A * C/P The mortality rate is D/(p*t) = E/(p*t) * A/E * P/A * C/P * D/C Key: E = exposures, A = acquisitions, P = progressed cases, C = complications, D = deaths, p = popn., t = time 8

Limitations Limitations of this particular classification system: - Exposure to risk cannot always be avoided - Not all diseases/conditions have preventable progression or complications, and some lack progression at all - Use of term stages for disease development (though not of prevention) may be confused with stage classifications of specific diseases (various cancers, CHF) Disadvantages of revising the classification of prevention: - Will have difficulty competing with a paradigm over half a century old and in wide use - New terms and 2 more divisions to remember 9

Limitations, contd. Limitations of any classification system: Cannot make universally applicable distinctions The real world is messy Prevention is complicated Can be ineffective if the disease entity to be prevented, and each stage for each disease, are not clearly defined Some articles identify attempts to prevent a complication as primary prevention of the complication Others considered similar interventions as secondary or tertiary prevention of the disease 10